Courses & Units
Drug Discovery, Development and Delivery CSA327
Introduction
This unit covers fundamental features and current methods involved in the drug development process. The unit emphasises on lead identification, lead optimisation and the introduction of new drugs into clinical practice. It deals with specific case studies that examine real drug discovery projects and how a range of drug design techniques are applied in each case. Novel drug delivery systems (e.g., recombinant DNA technology, liposome, gene therapy, monoclonal antibodies etc.) are also covered in detail. In addition, the study of chemical structure as a determinant of both the physicochemical properties and biological activity (including metabolic fate) of drug molecules of both synthetic and natural origin are also covered in detail.
Summary
| Unit name | Drug Discovery, Development and Delivery |
|---|---|
| Unit code | CSA327 |
| Credit points | 12.5 |
| College/School | College of Health and Medicine School of Pharmacy and Pharmacology |
| Discipline | Pharmacy |
| Coordinator | Doctor Rahul Patel |
| Available as an elective? | No |
| Delivered By | University of Tasmania |
Availability
This unit is currently unavailable.
Note
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).
Unit census dates currently displaying for 2023 are indicative and subject to change. Finalised census dates for 2023 will be available from the 1st October 2022. Note census date cutoff is 11.59pm AEST (AEDT during October to March).
Learning Outcomes
- Apply scientific principles of drug discovery and development in the clinical applications of medicines.
- Compare and evaluate novel drug delivery systems.
- Evaluate the pharmacological aspects of different drug actions and how this affects disease and body systems.
Fee Information
| Field of Education | Commencing Student Contribution 1,3 | Grandfathered Student Contribution 1,3 | Approved Pathway Course Student Contribution 2,3 | Domestic Full Fee 4 |
|---|---|---|---|---|
| not applicable |
1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.
If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.
Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.
Requisites
Prerequisites
CSA208 Biochemistry of Disease and Therapeutics and CSA231Teaching
| Teaching Pattern | Independent Learning (online modules) – 3hrs per week Workshop 2hrs weekly |
|---|---|
| Assessment | Good Clinical Practice Certification|Online Quizzes 1 (10%)|In-class Test (25%)|Data analysis (30%)|Problem Activated Learning (35%) |
| Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
| Required |
Required readings will be listed in the unit outline prior to the start of classes. |
Links | Booktopia textbook finder |
|---|
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.